Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review

Curr Microbiol. 2018 Dec;75(12):1667-1674. doi: 10.1007/s00284-018-1439-7. Epub 2018 Jan 22.

Abstract

Human papillomavirus (HPV) persistent infection is the necessary but not sufficient cause of cervical cancer. Other co-factors are required to induce cell transformation that will evolve to malignant cervical cancer. These co-factors include physical elements, other sexually transmitted infections, and immune response. Chlamydia trachomatis the most common bacterial sexually transmitted infection is often asymptomatic but causes various syndromes such as cervicitis, endometritis, pelvic inflammatory disease, and infertility. It is established that this bacterium is involved in cell proliferation process and inhibit apoptosis. Furthermore, C. trachomatis may induce chronic inflammation, interfere with immune response by decreasing the number of antigen presenting cells, and reduce the cell-mediated immunity allowing the persistence of HPV. However, it is unclear whether this bacterium plays a particular role in cervical cancer induction. We therefore aimed at enlightening the actual knowledge about the relationship between C. trachomatis and cervical cancer or precursor lesions through a systematic literature review. We summarized and analyzed the epidemiological data on C. trachomatis and its co-infection with HPV and their association to cervical cancer.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Chlamydia Infections / complications*
  • Chlamydia trachomatis / pathogenicity*
  • Coinfection / microbiology
  • Coinfection / virology
  • Female
  • Humans
  • Papillomavirus Infections / complications
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / microbiology*
  • Uterine Cervical Neoplasms / virology